news_6

Teva and Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Biosimilar to Rituxan® (rituximab) Available in the United States for This Indication

TRUXIMA is also now available for the treatment of Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) TEL...

news_6

Analysis on New Product Launches in Covid-19 Related Markets-Semiconductor Market in East Asia 2020-2024 | Growth of Consumer Electronics Market to Boost Growth | Technavio

LONDON--(BUSINESS WIRE)--#SemiconductorMarketSizeinEastAsia--Technavio has been monitoring the semiconductor market in East Asia and it is poised to grow by USD 186.19...

news_6

Utrecht University, Erasmus Medical Center and Harbour BioMed Researchers Report Discovery of Antibody that Blocks Novel Coronavirus SARS-CoV-2 Infection in Cells

Research Published in Nature Communications is Initial Step Towards Developing Fully Human Antibody Therapeutics and Diagnostics for Respiratory Disease COVID-19...